Dagla - diacylglycerol lipase, alpha Gene
Also Known as Nsddr
Species: Rattus norvegicus
Summary
Predicted to enable hydrolase activity. Predicted to be involved in several processes, including G protein-coupled receptor signaling pathway; diacylglycerol catabolic process; and retrograde trans-synaptic signaling by endocannabinoid. Predicted to act upstream of or within arachidonic acid metabolic process and neuroblast proliferation. Predicted to be located in early endosome membrane; synaptic membrane; and varicosity. Predicted to be integral component of postsynaptic membrane. Predicted to be active in postsynaptic membrane. Orthologous to human DAGLA (diacylglycerol Lipase alpha). [provided by Alliance of Genome Resources, Apr 2022]
Dagla Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001005886.2 | NP_001005886.1 | diacylglycerol lipase-alpha |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
diacylglycerol lipase-alpha |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P4406 | Abz-AGLA-Nba | 99.71% | Unkown | |
| HY-P4406A | Abz-AGLA-Nba TFA | 99.64% | Unkown | |
| HY-RS03520 | DAGLA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service